Internal Medicine, Cardiovascular Disease · Sugar Land, TX
NPI
1821046780
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
16651 Southwest Fwy, Mob 1, Suite 400
Sugar Land, TX, 77479
Phone (713) 776-9500
Groups this clinician bills Medicare through
Medicare paid, 2024
$523K
7,219 services
Medicare patients, 2024
2,038
Average age 76
Drug cost, 2024
$2.0M
12,710 prescriptions
Company payments, 2025
$4,709
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by B K Ellis was code 99215 (office e&m - established), 1,561 times for 961 patients. In total B K Ellis billed 7,219 services in 74 codes, and Medicare paid $523K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-02-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 1,561 | 961 | $122.04 | $191K |
| 93000 Electrocardiogram | Office | 1,493 | 927 | $9.64 | $14K |
| 93010 Electrocardiogram | Facility | 647 | 538 | $5.57 | $3,603 |
| 93306 Echocardiography (TTE/TEE) | Office | 643 | 640 | $128.46 | $83K |
| 93880 Duplex Scan - Extracranial Arteries | Office | 314 | 314 | $124.28 | $39K |
| 99233 Hospital E&M - Subsequent | Facility | 291 | 120 | $89.09 | $26K |
| 93306 Echocardiography (TTE/TEE) | Facility | 272 | 266 | $49.99 | $14K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 236 | 59 | $4.89 | $1,154 |
| 99152 Anesthesia | Facility | 210 | 194 | $9.19 | $1,931 |
| 93015 Electrocardiogram | Office | 193 | 193 | $44.60 | $8,608 |
| 93458 Percutaneous Transcatheterization | Facility | 147 | 145 | $196.86 | $29K |
| 99205 Office E&M - New | Office | 89 | 89 | $141.53 | $13K |
| 93923 Duplex Scan - Extremity Arteries | Office | 88 | 87 | $72.42 | $6,373 |
| 99232 Hospital E&M - Subsequent | Facility | 79 | 58 | $58.34 | $4,609 |
| A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 74 | 74 | $41.30 | $3,056 |
By year: 2022 $671K for 9,782 services; 2023 $643K for 9,181 services; 2024 $523K for 7,219 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 64 | 16 | $4.20 | $269 |
Medicare prescription drug claims, 2024
In 2024, the drug B K Ellis prescribed most often to Medicare patients was Metoprolol Succinate, with 1,060 prescriptions and refills. In total B K Ellis wrote 12,710 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 1,060 | 3,064 | 327 | $17K |
| Losartan Potassium Generic | 1,053 | 3,050 | 320 | $14K |
| Rosuvastatin Calcium Generic | 835 | 2,356 | 261 | $12K |
| Amlodipine Besylate Generic | 703 | 2,054 | 225 | $5,958 |
| Clopidogrel Clopidogrel Bisulfate | 641 | 1,889 | 187 | $9,091 |
| Atorvastatin Calcium Generic | 620 | 1,780 | 185 | $6,266 |
| Carvedilol Generic | 554 | 1,616 | 169 | $5,180 |
| Xarelto Rivaroxaban | 497 | 976 | 118 | $524K |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 473 | 1,292 | 136 | $8,441 |
| Hydralazine Hcl Generic | 451 | 1,255 | 147 | $7,560 |
| Labetalol Hcl Generic | 364 | 970 | 101 | $11K |
| Valsartan Generic | 345 | 952 | 108 | $15K |
| Furosemide Generic | 340 | 962 | 133 | $2,151 |
| Eliquis Apixaban | 278 | 560 | 77 | $318K |
| Flecainide Acetate Generic | 271 | 765 | 89 | $13K |
Brand drugs: 1,534 claims; generic drugs: 11,176 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid B K Ellis $4,709 ($4,709 in general payments such as food, travel and fees) from 18 companies. The largest payer was Abbott Laboratories with $2,657.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 11 | $2,657 |
| Novartis Pharmaceuticals Corporation NVS | 12 | $259 |
| Medtronic, Inc. MDT | 4 | $238 |
| Boston Scientific Corporation BSX | 10 | $205 |
| Amgen Inc. AMGN | 11 | $187 |
| Merck Sharp & Dohme LLC MRK | 11 | $182 |
| E.R. Squibb & Sons, L.L.C. BMY | 12 | $176 |
| Penumbra, Inc. PEN | 1 | $171 |
| AstraZeneca Pharmaceuticals LP AZN | 9 | $166 |
| Pfizer Inc. PFE | 8 | $138 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.